메뉴 건너뛰기




Volumn 31, Issue 6, 2016, Pages 782-790

Glycation in Parkinson's disease and Alzheimer's disease

Author keywords

Alzheimer's disease; Glycation; Neurodegenerative diseases; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; METFORMIN;

EID: 84959455993     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26566     Document Type: Review
Times cited : (108)

References (140)
  • 1
    • 0035856980 scopus 로고    scopus 로고
    • Biochemistry and molecular cell biology of diabetic complications
    • Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414(6865):813-820.
    • (2001) Nature , vol.414 , Issue.6865 , pp. 813-820
    • Brownlee, M.1
  • 2
    • 0036167208 scopus 로고    scopus 로고
    • Diabetes and advanced glycation endproducts
    • Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002;251(2):87-101.
    • (2002) J Intern Med , vol.251 , Issue.2 , pp. 87-101
    • Vlassara, H.1    Palace, M.R.2
  • 3
    • 0000916315 scopus 로고
    • Action des acides amines sur les sucre: formation des melanoidines par voie methodique
    • Maillard L. Action des acides amines sur les sucre: formation des melanoidines par voie methodique. C R Hebd Seances Acad Sci 1912;154:66-68.
    • (1912) C R Hebd Seances Acad Sci , vol.154 , pp. 66-68
    • Maillard, L.1
  • 4
    • 42449109476 scopus 로고    scopus 로고
    • Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications
    • Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nature clinical practice Endocrinol Metab 2008;4(5):285-293.
    • (2008) Nature clinical practice Endocrinol Metab , vol.4 , Issue.5 , pp. 285-293
    • Yan, S.F.1    Ramasamy, R.2    Schmidt, A.M.3
  • 5
    • 23744447530 scopus 로고    scopus 로고
    • Dicarbonyl intermediates in the maillard reaction
    • Thornalley PJ. Dicarbonyl intermediates in the maillard reaction. Ann N Y Acad Sci 2005;1043:111-117.
    • (2005) Ann N Y Acad Sci , vol.1043 , pp. 111-117
    • Thornalley, P.J.1
  • 6
    • 0027396022 scopus 로고
    • The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal
    • Phillips SA, Thornalley PJ. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 1993;212(1):101-105.
    • (1993) Eur J Biochem , vol.212 , Issue.1 , pp. 101-105
    • Phillips, S.A.1    Thornalley, P.J.2
  • 7
    • 0021471746 scopus 로고
    • Acid-base catalysis of the elimination and isomerization reactions of triose phosphates
    • Richard JP. Acid-base catalysis of the elimination and isomerization reactions of triose phosphates. J Am Chem Soc 1984;106(17):4926-4936.
    • (1984) J Am Chem Soc , vol.106 , Issue.17 , pp. 4926-4936
    • Richard, J.P.1
  • 8
    • 0037093336 scopus 로고    scopus 로고
    • Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin
    • Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin. Biochem J 2002;364(Pt 1):1-14.
    • (2002) Biochem J , vol.364 , pp. 1-14
    • Ahmed, N.1    Argirov, O.K.2    Minhas, H.S.3    Cordeiro, C.A.4    Thornalley, P.J.5
  • 9
    • 0037093522 scopus 로고    scopus 로고
    • Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence
    • Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J 2002;364(Pt 1):15-24.
    • (2002) Biochem J , vol.364 , pp. 15-24
    • Ahmed, N.1    Thornalley, P.J.2
  • 10
    • 0033603599 scopus 로고    scopus 로고
    • Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts
    • Oya T, Hattori N, Mizuno Y, et al. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 1999;274(26):18492-18502.
    • (1999) J Biol Chem , vol.274 , Issue.26 , pp. 18492-18502
    • Oya, T.1    Hattori, N.2    Mizuno, Y.3
  • 11
    • 0031214523 scopus 로고    scopus 로고
    • Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct
    • Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 1997;344(1):29-36.
    • (1997) Arch Biochem Biophys , vol.344 , Issue.1 , pp. 29-36
    • Shipanova, I.N.1    Glomb, M.A.2    Nagaraj, R.H.3
  • 12
    • 0030919275 scopus 로고    scopus 로고
    • N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins
    • Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 1997;324 (Pt 2):565-570.
    • (1997) Biochem J , vol.324 , pp. 565-570
    • Ahmed, M.U.1    Brinkmann Frye, E.2    Degenhardt, T.P.3    Thorpe, S.R.4    Baynes, J.W.5
  • 13
    • 0032563120 scopus 로고    scopus 로고
    • Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins
    • Frye EB, Degenhardt TP, Thorpe SR, Baynes JW. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem 1998;273(30):18714-18719.
    • (1998) J Biol Chem , vol.273 , Issue.30 , pp. 18714-18719
    • Frye, E.B.1    Degenhardt, T.P.2    Thorpe, S.R.3    Baynes, J.W.4
  • 14
    • 53849092368 scopus 로고    scopus 로고
    • Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress
    • Rabbani N, Thornalley PJ. Dicarbonyls linked to damage in the powerhouse: glycation of mitochondrial proteins and oxidative stress. Biochem Soc Trans 2008;36(Pt 5):1045-1050.
    • (2008) Biochem Soc Trans , vol.36 , pp. 1045-1050
    • Rabbani, N.1    Thornalley, P.J.2
  • 15
    • 0033571012 scopus 로고    scopus 로고
    • Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
    • Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 1999;344 Pt 1:109-116.
    • (1999) Biochem J , vol.344 , pp. 109-116
    • Thornalley, P.J.1    Langborg, A.2    Minhas, H.S.3
  • 17
    • 0014217148 scopus 로고
    • Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate
    • Monder C. Alpha-keto aldehyde dehydrogenase, an enzyme that catalyzes the enzymic oxidation of methylglyoxal to pyruvate. J Biol Chem 1967;242(20):4603-4609.
    • (1967) J Biol Chem , vol.242 , Issue.20 , pp. 4603-4609
    • Monder, C.1
  • 18
    • 0026646131 scopus 로고
    • Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications
    • Vander Jagt DL, Robinson B, Taylor KK, Hunsaker LA. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J Biol Chem 1992;267(7):4364-4369.
    • (1992) J Biol Chem , vol.267 , Issue.7 , pp. 4364-4369
    • Vander Jagt, D.L.1    Robinson, B.2    Taylor, K.K.3    Hunsaker, L.A.4
  • 19
    • 0031847669 scopus 로고    scopus 로고
    • Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes
    • Izaguirre G, Kikonyogo A, Pietruszko R. Methylglyoxal as substrate and inhibitor of human aldehyde dehydrogenase: comparison of kinetic properties among the three isozymes. Comp Biochem Physiol B Biochem Mol Biol 1998;119(4):747-754.
    • (1998) Comp Biochem Physiol B Biochem Mol Biol , vol.119 , Issue.4 , pp. 747-754
    • Izaguirre, G.1    Kikonyogo, A.2    Pietruszko, R.3
  • 20
    • 84901052694 scopus 로고    scopus 로고
    • ROS function in redox signaling and oxidative stress
    • Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014;24(10):R453-462.
    • (2014) Curr Biol , vol.24 , Issue.10 , pp. R453-R462
    • Schieber, M.1    Chandel, N.S.2
  • 22
    • 0022480624 scopus 로고
    • Kinetic analysis of glycation as a tool for assessing the half-life of proteins
    • Schleicher E, Wieland OH. Kinetic analysis of glycation as a tool for assessing the half-life of proteins. Biochim Biophys Act 1986;884(1):199-205.
    • (1986) Biochim Biophys Act , vol.884 , Issue.1 , pp. 199-205
    • Schleicher, E.1    Wieland, O.H.2
  • 23
  • 24
    • 84911423174 scopus 로고    scopus 로고
    • The prevalence of Parkinson's disease: a systematic review and meta-analysis
    • Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014;29(13):1583-1590.
    • (2014) Mov Disord , vol.29 , Issue.13 , pp. 1583-1590
    • Pringsheim, T.1    Jette, N.2    Frolkis, A.3    Steeves, T.D.4
  • 26
    • 0032568534 scopus 로고    scopus 로고
    • alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
    • Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 1998;95(11):6469-6473.
    • (1998) Proc Natl Acad Sci U S A , vol.95 , Issue.11 , pp. 6469-6473
    • Spillantini, M.G.1    Crowther, R.A.2    Jakes, R.3    Hasegawa, M.4    Goedert, M.5
  • 27
    • 10544234193 scopus 로고    scopus 로고
    • Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
    • Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274(5290):1197-1199.
    • (1996) Science , vol.274 , Issue.5290 , pp. 1197-1199
    • Polymeropoulos, M.H.1    Higgins, J.J.2    Golbe, L.I.3
  • 28
    • 0029981526 scopus 로고    scopus 로고
    • Neuropathology of Parkinson's disease
    • Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996;55(3):259-272.
    • (1996) J Neuropathol Exp Neurol , vol.55 , Issue.3 , pp. 259-272
    • Forno, L.S.1
  • 29
    • 32544432029 scopus 로고    scopus 로고
    • Non-motor symptoms of Parkinson's disease: diagnosis and management
    • National Institute for Clinical E
    • Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5(3):235-245.
    • (2006) Lancet Neurol , vol.5 , Issue.3 , pp. 235-245
    • Chaudhuri, K.R.1    Healy, D.G.2    Schapira, A.H.3
  • 31
    • 84872551783 scopus 로고    scopus 로고
    • Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration
    • Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013;33(Suppl 1):S123-139.
    • (2013) J Alzheimers Dis , vol.33 , pp. S123-S139
    • Wang, J.Z.1    Xia, Y.Y.2    Grundke-Iqbal, I.3    Iqbal, K.4
  • 32
    • 75149136696 scopus 로고    scopus 로고
    • Alzheimer's disease and the amyloid-beta peptide
    • Murphy MP, LeVine H 3rd. Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 2010;19(1):311-323.
    • (2010) J Alzheimers Dis , vol.19 , Issue.1 , pp. 311-323
    • Murphy, M.P.1    LeVine, H.2
  • 33
    • 84878534880 scopus 로고    scopus 로고
    • Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer's disease
    • Koehler NK, Stransky E, Shing M, et al. Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer's disease. PLoS One 2013;8(5):e64649.
    • (2013) PLoS One , vol.8 , Issue.5 , pp. e64649
    • Koehler, N.K.1    Stransky, E.2    Shing, M.3
  • 34
    • 84893652011 scopus 로고    scopus 로고
    • Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease
    • Mattsson N, Insel P, Tosun D, et al. Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One 2013;8(12):e85443.
    • (2013) PLoS One , vol.8 , Issue.12 , pp. e85443
    • Mattsson, N.1    Insel, P.2    Tosun, D.3
  • 35
    • 0342514665 scopus 로고    scopus 로고
    • Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein
    • Yang F, Ueda K, Chen P, Ashe KH, Cole GM. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res 2000;853(2):381-383.
    • (2000) Brain Res , vol.853 , Issue.2 , pp. 381-383
    • Yang, F.1    Ueda, K.2    Chen, P.3    Ashe, K.H.4    Cole, G.M.5
  • 36
    • 84881424881 scopus 로고    scopus 로고
    • Alzheimer's Disease Neuroimaging I. alpha-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment
    • Korff A, Liu C, Ginghina C, Shi M, Zhang J, Alzheimer's Disease Neuroimaging I. alpha-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment. J Alzheimers Dis 2013;36(4):679-688.
    • (2013) J Alzheimers Dis , vol.36 , Issue.4 , pp. 679-688
    • Korff, A.1    Liu, C.2    Ginghina, C.3    Shi, M.4    Zhang, J.5
  • 37
    • 84885699313 scopus 로고    scopus 로고
    • Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
    • Kang JH, Irwin DJ, Chen-Plotkin AS, et al. Association of cerebrospinal fluid beta-amyloid 1-42, T-tau, P-tau181, and alpha-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurol 2013;70(10):1277-1287.
    • (2013) JAMA Neurol , vol.70 , Issue.10 , pp. 1277-1287
    • Kang, J.H.1    Irwin, D.J.2    Chen-Plotkin, A.S.3
  • 39
    • 36249019041 scopus 로고    scopus 로고
    • Prospective study of dietary pattern and risk of Parkinson disease
    • Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 2007;86(5):1486-1494.
    • (2007) Am J Clin Nutr , vol.86 , Issue.5 , pp. 1486-1494
    • Gao, X.1    Chen, H.2    Fung, T.T.3
  • 40
    • 84925794942 scopus 로고    scopus 로고
    • Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence
    • Perrone L, Grant WB. Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer's disease incidence and prevalence. J Alzheimers Dis 2015;45(3):965-979.
    • (2015) J Alzheimers Dis , vol.45 , Issue.3 , pp. 965-979
    • Perrone, L.1    Grant, W.B.2
  • 41
    • 0039267710 scopus 로고
    • Progression and prognosis in Parkinson's disease
    • Schwab RS. Progression and prognosis in Parkinson's disease. J Nerv Ment Dis 1960;130:556-566.
    • (1960) J Nerv Ment Dis , vol.130 , pp. 556-566
    • Schwab, R.S.1
  • 42
    • 34548206868 scopus 로고
    • [Clinical experience with tolbutamide in Parkinson's disease]
    • Barbeau A, Giguere R, Hardy J. [Clinical experience with tolbutamide in Parkinson's disease]. Union Med Can 1961;90:147-151.
    • (1961) Union Med Can , vol.90 , pp. 147-151
    • Barbeau, A.1    Giguere, R.2    Hardy, J.3
  • 43
    • 0016318795 scopus 로고
    • Glucose intolerance in Parkinson's disease
    • Lipman IJ, Boykin ME, Flora RE. Glucose intolerance in Parkinson's disease. J Chron Dis 1974;27(11-12):573-579.
    • (1974) J Chron Dis , vol.27 , Issue.11-12 , pp. 573-579
    • Lipman, I.J.1    Boykin, M.E.2    Flora, R.E.3
  • 44
    • 0027561888 scopus 로고
    • The relationship between diabetes mellitus and Parkinson's disease
    • Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 1993;69(1-4):125-130.
    • (1993) Int J Neurosci , vol.69 , Issue.1-4 , pp. 125-130
    • Sandyk, R.1
  • 45
    • 0015145828 scopus 로고
    • Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-dopa
    • Boyd AE, 3rd, Lebovitz HE, Feldman JM. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-dopa. J Clin Endocrinol Metab 1971;33(5):829-837.
    • (1971) J Clin Endocrinol Metab , vol.33 , Issue.5 , pp. 829-837
    • Boyd, A.E.1    Lebovitz, H.E.2    Feldman, J.M.3
  • 47
    • 79956218430 scopus 로고    scopus 로고
    • Diabetes and risk of Parkinson's disease
    • Xu Q, Park Y, Huang X, et al. Diabetes and risk of Parkinson's disease. Diabetes Care 2011;34(4):910-915.
    • (2011) Diabetes Care , vol.34 , Issue.4 , pp. 910-915
    • Xu, Q.1    Park, Y.2    Huang, X.3
  • 49
    • 84863625218 scopus 로고    scopus 로고
    • Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
    • Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G. Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology 2012;78(19):1507-1511.
    • (2012) Neurology , vol.78 , Issue.19 , pp. 1507-1511
    • Cereda, E.1    Barichella, M.2    Cassani, E.3    Caccialanza, R.4    Pezzoli, G.5
  • 51
    • 84859049352 scopus 로고    scopus 로고
    • Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis
    • Cereda E, Barichella M, Pedrolli C, et al. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011;34(12):2614-2623.
    • (2011) Diabetes Care , vol.34 , Issue.12 , pp. 2614-2623
    • Cereda, E.1    Barichella, M.2    Pedrolli, C.3
  • 53
    • 84908160592 scopus 로고    scopus 로고
    • Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies
    • Lu L, Fu DL, Li HQ, Liu AJ, Li JH, Zheng GQ. Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies. PLoS One 2014;9(1):e85781.
    • (2014) PLoS One , vol.9 , Issue.1 , pp. e85781
    • Lu, L.1    Fu, D.L.2    Li, H.Q.3    Liu, A.J.4    Li, J.H.5    Zheng, G.Q.6
  • 54
    • 84855830535 scopus 로고    scopus 로고
    • Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics)
    • Uchiki T, Weikel KA, Jiao W, et al. Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell 2012;11(1):1-13.
    • (2012) Aging Cell , vol.11 , Issue.1 , pp. 1-13
    • Uchiki, T.1    Weikel, K.A.2    Jiao, W.3
  • 55
    • 0030459456 scopus 로고    scopus 로고
    • High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils
    • Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metab Clin Exp 1996;45(12):1539-1546.
    • (1996) Metab Clin Exp , vol.45 , Issue.12 , pp. 1539-1546
    • Ikemoto, S.1    Takahashi, M.2    Tsunoda, N.3    Maruyama, K.4    Itakura, H.5    Ezaki, O.6
  • 56
    • 0028961355 scopus 로고
    • High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice
    • Ikemoto S, Thompson KS, Takahashi M, Itakura H, Lane MD, Ezaki O. High fat diet-induced hyperglycemia: prevention by low level expression of a glucose transporter (GLUT4) minigene in transgenic mice. Proc Natl Acad Sci U S A 1995;92(8):3096-3099.
    • (1995) Proc Natl Acad Sci U S A , vol.92 , Issue.8 , pp. 3096-3099
    • Ikemoto, S.1    Thompson, K.S.2    Takahashi, M.3    Itakura, H.4    Lane, M.D.5    Ezaki, O.6
  • 57
    • 77957575432 scopus 로고    scopus 로고
    • Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet
    • Morris JK, Bomhoff GL, Stanford JA, Geiger PC. Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 2010;299(4):R1082-1090.
    • (2010) Am J Physiol Regul Integr Comp Physiol , vol.299 , Issue.4 , pp. R1082-R1090
    • Morris, J.K.1    Bomhoff, G.L.2    Stanford, J.A.3    Geiger, P.C.4
  • 58
    • 13844275515 scopus 로고    scopus 로고
    • Enhanced susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity
    • Choi JY, Jang EH, Park CS, Kang JH. Enhanced susceptibility to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity in high-fat diet-induced obesity. Free Radic Biol Med 2005;38(6):806-816.
    • (2005) Free Radic Biol Med , vol.38 , Issue.6 , pp. 806-816
    • Choi, J.Y.1    Jang, E.H.2    Park, C.S.3    Kang, J.H.4
  • 59
    • 84918804167 scopus 로고    scopus 로고
    • Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice
    • Rotermund C, Truckenmuller FM, Schell H, Kahle PJ. Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice. J Neurochem 2014;131(6):848-858.
    • (2014) J Neurochem , vol.131 , Issue.6 , pp. 848-858
    • Rotermund, C.1    Truckenmuller, F.M.2    Schell, H.3    Kahle, P.J.4
  • 60
    • 34948816643 scopus 로고    scopus 로고
    • Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes
    • Han Y, Randell E, Vasdev S, et al. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem 2007;305(1-2):123-131.
    • (2007) Mol Cell Biochem , vol.305 , Issue.1-2 , pp. 123-131
    • Han, Y.1    Randell, E.2    Vasdev, S.3
  • 61
    • 0028292698 scopus 로고
    • Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications
    • McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sc 1994;87(1):21-29.
    • (1994) Clin Sc , vol.87 , Issue.1 , pp. 21-29
    • McLellan, A.C.1    Thornalley, P.J.2    Benn, J.3    Sonksen, P.H.4
  • 62
    • 35248894440 scopus 로고    scopus 로고
    • Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus
    • Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin Biochem 2007;40(16-17):1232-1239.
    • (2007) Clin Biochem , vol.40 , Issue.16-17 , pp. 1232-1239
    • Wang, H.1    Meng, Q.H.2    Gordon, J.R.3    Khandwala, H.4    Wu, L.5
  • 63
    • 84883786992 scopus 로고    scopus 로고
    • Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats
    • Dhar I, Dhar A, Wu L, Desai KM. Increased methylglyoxal formation with upregulation of renin angiotensin system in fructose fed Sprague Dawley rats. PLoS One 2013;8(9):e74212.
    • (2013) PLoS One , vol.8 , Issue.9 , pp. e74212
    • Dhar, I.1    Dhar, A.2    Wu, L.3    Desai, K.M.4
  • 64
    • 23344435471 scopus 로고    scopus 로고
    • Vascular methylglyoxal metabolism and the development of hypertension
    • Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens 2005;23(8):1565-1573.
    • (2005) J Hypertens , vol.23 , Issue.8 , pp. 1565-1573
    • Wang, X.1    Desai, K.2    Chang, T.3    Wu, L.4
  • 65
    • 40449113838 scopus 로고    scopus 로고
    • Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats
    • Wang X, Jia X, Chang T, Desai K, Wu L. Attenuation of hypertension development by scavenging methylglyoxal in fructose-treated rats. J Hypertens 2008;26(4):765-772.
    • (2008) J Hypertens , vol.26 , Issue.4 , pp. 765-772
    • Wang, X.1    Jia, X.2    Chang, T.3    Desai, K.4    Wu, L.5
  • 66
    • 84926464959 scopus 로고    scopus 로고
    • High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature
    • Li W, Maloney RE, Aw TY. High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature. Redox Biol 2015;5:80-90.
    • (2015) Redox Biol , vol.5 , pp. 80-90
    • Li, W.1    Maloney, R.E.2    Aw, T.Y.3
  • 67
    • 0030597071 scopus 로고    scopus 로고
    • Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
    • Castellani R, Smith MA, Richey PL, Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res 1996;737(1-2):195-200.
    • (1996) Brain Res , vol.737 , Issue.1-2 , pp. 195-200
    • Castellani, R.1    Smith, M.A.2    Richey, P.L.3    Perry, G.4
  • 69
    • 0034468706 scopus 로고    scopus 로고
    • Crosslinking of alpha-synuclein by advanced glycation endproducts-an early pathophysiological step in Lewy body formation?
    • Munch G, Luth HJ, Wong A, et al. Crosslinking of alpha-synuclein by advanced glycation endproducts-an early pathophysiological step in Lewy body formation? J Chem Neuroanat 2000;20(3-4):253-257.
    • (2000) J Chem Neuroanat , vol.20 , Issue.3-4 , pp. 253-257
    • Munch, G.1    Luth, H.J.2    Wong, A.3
  • 70
    • 77957109627 scopus 로고    scopus 로고
    • N(varepsilon)-(carboxymethyl)lysine linkage to alpha-synuclein and involvement of advanced glycation end products in alpha-synuclein deposits in an MPTP-intoxicated mouse model
    • Choi YG, Lim S. N(varepsilon)-(carboxymethyl)lysine linkage to alpha-synuclein and involvement of advanced glycation end products in alpha-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie 2010;92(10):1379-1386.
    • (2010) Biochimie , vol.92 , Issue.10 , pp. 1379-1386
    • Choi, Y.G.1    Lim, S.2
  • 71
    • 48249103154 scopus 로고    scopus 로고
    • Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation
    • Shaikh S, Nicholson LF. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. J Neurosci Res 2008;86(9):2071-2082.
    • (2008) J Neurosci Res , vol.86 , Issue.9 , pp. 2071-2082
    • Shaikh, S.1    Nicholson, L.F.2
  • 72
    • 59349088294 scopus 로고    scopus 로고
    • The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process
    • Lee D, Park CW, Paik SR, Choi KY. The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process. Biochim Biophys Act 2009;1794(3):421-430.
    • (2009) Biochim Biophys Act , vol.1794 , Issue.3 , pp. 421-430
    • Lee, D.1    Park, C.W.2    Paik, S.R.3    Choi, K.Y.4
  • 73
    • 84885468645 scopus 로고    scopus 로고
    • Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease
    • Guerrero E, Vasudevaraju P, Hegde ML, Britton GB, Rao KS. Recent advances in alpha-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease. Mol Neurobiol 2013;47(2):525-536.
    • (2013) Mol Neurobiol , vol.47 , Issue.2 , pp. 525-536
    • Guerrero, E.1    Vasudevaraju, P.2    Hegde, M.L.3    Britton, G.B.4    Rao, K.S.5
  • 74
    • 77953408910 scopus 로고    scopus 로고
    • Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies
    • Outeiro TF, Kazantsev A. Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies. Perspect Medic Chem 2008;2:41-49.
    • (2008) Perspect Medic Chem , vol.2 , pp. 41-49
    • Outeiro, T.F.1    Kazantsev, A.2
  • 75
    • 44849125207 scopus 로고    scopus 로고
    • Formation of toxic oligomeric alpha-synuclein species in living cells
    • Outeiro TF, Putcha P, Tetzlaff JE, et al. Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 2008;3(4):e1867.
    • (2008) PLoS One , vol.3 , Issue.4 , pp. e1867
    • Outeiro, T.F.1    Putcha, P.2    Tetzlaff, J.E.3
  • 76
    • 79952742454 scopus 로고    scopus 로고
    • In vivo demonstration that alpha-synuclein oligomers are toxic
    • Winner B, Jappelli R, Maji SK, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A 2011;108(10):4194-4199.
    • (2011) Proc Natl Acad Sci U S A , vol.108 , Issue.10 , pp. 4194-4199
    • Winner, B.1    Jappelli, R.2    Maji, S.K.3
  • 77
    • 79951581055 scopus 로고    scopus 로고
    • Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress
    • Kurz A, Rabbani N, Walter M, et al. Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress. Cell Mol Life Sci 2011;68(4):721-733.
    • (2011) Cell Mol Life Sci , vol.68 , Issue.4 , pp. 721-733
    • Kurz, A.1    Rabbani, N.2    Walter, M.3
  • 78
    • 4244040278 scopus 로고    scopus 로고
    • Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors
    • Thornalley PJ. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Inter 1998;111-112:137-151.
    • (1998) Chem Biol Inter , vol.111 , Issue.112 , pp. 137-151
    • Thornalley, P.J.1
  • 79
    • 0027185713 scopus 로고
    • Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
    • Jenner P. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Act Neurol Scand Suppl 1993;146:6-13.
    • (1993) Act Neurol Scand Suppl , vol.146 , pp. 6-13
    • Jenner, P.1
  • 80
    • 0028075410 scopus 로고
    • Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
    • Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 1994;36(3):348-355.
    • (1994) Ann Neurol , vol.36 , Issue.3 , pp. 348-355
    • Sian, J.1    Dexter, D.T.2    Lees, A.J.3
  • 81
    • 33646482095 scopus 로고    scopus 로고
    • Age-dependent changes of glyoxalase I expression in human brain
    • Kuhla B, Boeck K, Luth HJ, et al. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging 2006;27(6):815-822.
    • (2006) Neurobiol Aging , vol.27 , Issue.6 , pp. 815-822
    • Kuhla, B.1    Boeck, K.2    Luth, H.J.3
  • 82
    • 33745140532 scopus 로고    scopus 로고
    • Proteasome dysfunction in aged human alpha-synuclein transgenic mice
    • Chen L, Thiruchelvam MJ, Madura K, Richfield EK. Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiol Dis 2006;23(1):120-126.
    • (2006) Neurobiol Dis , vol.23 , Issue.1 , pp. 120-126
    • Chen, L.1    Thiruchelvam, M.J.2    Madura, K.3    Richfield, E.K.4
  • 83
    • 0035870881 scopus 로고    scopus 로고
    • Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
    • Tanaka Y, Engelender S, Igarashi S, et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 2001;10(9):919-926.
    • (2001) Hum Mol Genet , vol.10 , Issue.9 , pp. 919-926
    • Tanaka, Y.1    Engelender, S.2    Igarashi, S.3
  • 84
    • 84863518914 scopus 로고    scopus 로고
    • DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway
    • Im JY, Lee KW, Woo JM, Junn E, Mouradian MM. DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 2012;21(13):3013-3024.
    • (2012) Hum Mol Genet , vol.21 , Issue.13 , pp. 3013-3024
    • Im, J.Y.1    Lee, K.W.2    Woo, J.M.3    Junn, E.4    Mouradian, M.M.5
  • 85
    • 84858307371 scopus 로고    scopus 로고
    • Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation
    • Xue M, Rabbani N, Momiji H, et al. Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation. Biochem J 2012;443(1):213-222.
    • (2012) Biochem J , vol.443 , Issue.1 , pp. 213-222
    • Xue, M.1    Rabbani, N.2    Momiji, H.3
  • 86
    • 84864021706 scopus 로고    scopus 로고
    • Human DJ-1 and its homologs are novel glyoxalases
    • Lee JY, Song J, Kwon K, et al. Human DJ-1 and its homologs are novel glyoxalases. Hum Mol Genet 2012;21(14):3215-3225.
    • (2012) Hum Mol Genet , vol.21 , Issue.14 , pp. 3215-3225
    • Lee, J.Y.1    Song, J.2    Kwon, K.3
  • 87
    • 84922264295 scopus 로고    scopus 로고
    • Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues
    • Richarme G, Mihoub M, Dairou J, Bui LC, Leger T, Lamouri A. Parkinsonism-associated protein DJ-1/Park7 is a major protein deglycase that repairs methylglyoxal- and glyoxal-glycated cysteine, arginine, and lysine residues. J Biol Chem 2015;290(3):1885-1897.
    • (2015) J Biol Chem , vol.290 , Issue.3 , pp. 1885-1897
    • Richarme, G.1    Mihoub, M.2    Dairou, J.3    Bui, L.C.4    Leger, T.5    Lamouri, A.6
  • 88
    • 0037454697 scopus 로고    scopus 로고
    • Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes
    • Beisswenger PJ, Howell SK, Smith K, Szwergold BS. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Act 2003;1637(1):98-106.
    • (2003) Biochim Biophys Act , vol.1637 , Issue.1 , pp. 98-106
    • Beisswenger, P.J.1    Howell, S.K.2    Smith, K.3    Szwergold, B.S.4
  • 89
    • 84942600616 scopus 로고    scopus 로고
    • Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population
    • Liu L, Xiong N, Zhang P, et al. Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population. PLoS One 2015;10(8):e0135425.
    • (2015) PLoS One , vol.10 , Issue.8 , pp. e0135425
    • Liu, L.1    Xiong, N.2    Zhang, P.3
  • 90
    • 84863423974 scopus 로고    scopus 로고
    • Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains
    • Deng Y, Zhang Y, Li Y, et al. Occurrence and distribution of salsolinol-like compound, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J Neural Transm 2012;119(4):435-441.
    • (2012) J Neural Transm , vol.119 , Issue.4 , pp. 435-441
    • Deng, Y.1    Zhang, Y.2    Li, Y.3
  • 91
    • 84893826232 scopus 로고    scopus 로고
    • Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes
    • Song DW, Xin N, Xie BJ, et al. Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes. Int J Mol Med 2014;33(3):736-742.
    • (2014) Int J Mol Med , vol.33 , Issue.3 , pp. 736-742
    • Song, D.W.1    Xin, N.2    Xie, B.J.3
  • 92
    • 84931331883 scopus 로고    scopus 로고
    • A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease
    • Xie B, Lin F, Ullah K, et al. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease. Biochem Biophys Res Commun 2015;459(3):361-366.
    • (2015) Biochem Biophys Res Commun , vol.459 , Issue.3 , pp. 361-366
    • Xie, B.1    Lin, F.2    Ullah, K.3
  • 93
    • 84874455392 scopus 로고    scopus 로고
    • Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship
    • Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 2013;35:152-160.
    • (2013) Epidemiol Rev , vol.35 , pp. 152-160
    • Vagelatos, N.T.1    Eslick, G.D.2
  • 95
    • 71349085957 scopus 로고    scopus 로고
    • Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
    • Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2010;31(2):224-243.
    • (2010) Neurobiol Aging , vol.31 , Issue.2 , pp. 224-243
    • Moloney, A.M.1    Griffin, R.J.2    Timmons, S.3    O'Connor, R.4    Ravid, R.5    O'Neill, C.6
  • 96
    • 1842785174 scopus 로고    scopus 로고
    • Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus
    • Trudeau F, Gagnon S, Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur J Pharmacol 2004;490(1-3):177-186.
    • (2004) Eur J Pharmacol , vol.490 , Issue.1-3 , pp. 177-186
    • Trudeau, F.1    Gagnon, S.2    Massicotte, G.3
  • 97
    • 84855613853 scopus 로고    scopus 로고
    • Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial
    • Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 2012;69(1):29-38.
    • (2012) Arch Neurol , vol.69 , Issue.1 , pp. 29-38
    • Craft, S.1    Baker, L.D.2    Montine, T.J.3
  • 98
    • 84860599622 scopus 로고    scopus 로고
    • Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities
    • Carvalho C, Cardoso S, Correia SC, et al. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 2012;61(5):1234-1242.
    • (2012) Diabetes , vol.61 , Issue.5 , pp. 1234-1242
    • Carvalho, C.1    Cardoso, S.2    Correia, S.C.3
  • 99
    • 0028363366 scopus 로고
    • Advanced glycation end products contribute to amyloidosis in Alzheimer disease
    • Vitek MP, Bhattacharya K, Glendening JM, et al. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci U S A 1994;91(11):4766-4770.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , Issue.11 , pp. 4766-4770
    • Vitek, M.P.1    Bhattacharya, K.2    Glendening, J.M.3
  • 100
    • 0028233977 scopus 로고
    • Advanced Maillard reaction end products are associated with Alzheimer disease pathology
    • Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A 1994;91(12):5710-5714.
    • (1994) Proc Natl Acad Sci U S A , vol.91 , Issue.12 , pp. 5710-5714
    • Smith, M.A.1    Taneda, S.2    Richey, P.L.3
  • 101
    • 17744380261 scopus 로고    scopus 로고
    • Albumin antioxidant capacity is modified by methylglyoxal
    • Faure P, Troncy L, Lecomte M, et al. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab 2005;31(2):169-177.
    • (2005) Diabetes Metab , vol.31 , Issue.2 , pp. 169-177
    • Faure, P.1    Troncy, L.2    Lecomte, M.3
  • 102
    • 0028959714 scopus 로고
    • Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?
    • Kimura T, Takamatsu J, Araki N, et al. Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease? Neuroreport 1995;6(6):866-868.
    • (1995) Neuroreport , vol.6 , Issue.6 , pp. 866-868
    • Kimura, T.1    Takamatsu, J.2    Araki, N.3
  • 103
    • 0029133373 scopus 로고
    • Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain
    • Ledesma MD, Bonay P, Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J Neurochem 1995;65(4):1658-1664.
    • (1995) J Neurochem , vol.65 , Issue.4 , pp. 1658-1664
    • Ledesma, M.D.1    Bonay, P.2    Avila, J.3
  • 104
    • 33750899858 scopus 로고    scopus 로고
    • Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis
    • Chen K, Maley J, Yu PH. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis. J Neurochem 2006;99(5):1413-1424.
    • (2006) J Neurochem , vol.99 , Issue.5 , pp. 1413-1424
    • Chen, K.1    Maley, J.2    Yu, P.H.3
  • 105
    • 0028065142 scopus 로고
    • Analysis of microtubule-associated protein tau glycation in paired helical filaments
    • Ledesma MD, Bonay P, Colaco C, Avila J. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994;269(34):21614-21619.
    • (1994) J Biol Chem , vol.269 , Issue.34 , pp. 21614-21619
    • Ledesma, M.D.1    Bonay, P.2    Colaco, C.3    Avila, J.4
  • 106
    • 0042207369 scopus 로고    scopus 로고
    • Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide
    • Munch G, Mayer S, Michaelis J, et al. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Act 1997;1360(1):17-29.
    • (1997) Biochim Biophys Act , vol.1360 , Issue.1 , pp. 17-29
    • Munch, G.1    Mayer, S.2    Michaelis, J.3
  • 107
    • 9644273963 scopus 로고    scopus 로고
    • Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro
    • Necula M, Kuret J. Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J Biol Chem 2004;279(48):49694-49703.
    • (2004) J Biol Chem , vol.279 , Issue.48 , pp. 49694-49703
    • Necula, M.1    Kuret, J.2
  • 108
    • 0346504002 scopus 로고    scopus 로고
    • Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity
    • Woltjer RL, Maezawa I, Ou JJ, Montine KS, Montine TJ. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimers Dis 2003;5(6):467-476.
    • (2003) J Alzheimers Dis , vol.5 , Issue.6 , pp. 467-476
    • Woltjer, R.L.1    Maezawa, I.2    Ou, J.J.3    Montine, K.S.4    Montine, T.J.5
  • 109
    • 77954142794 scopus 로고    scopus 로고
    • Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species
    • Ko SY, Lin YP, Lin YS, Chang SS. Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species. Free Radic Biol Med 2010;49(3):474-480.
    • (2010) Free Radic Biol Med , vol.49 , Issue.3 , pp. 474-480
    • Ko, S.Y.1    Lin, Y.P.2    Lin, Y.S.3    Chang, S.S.4
  • 110
    • 12244312488 scopus 로고    scopus 로고
    • Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells
    • Liu BF, Miyata S, Hirota Y, et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 2003;63(3):947-957.
    • (2003) Kidney Int , vol.63 , Issue.3 , pp. 947-957
    • Liu, B.F.1    Miyata, S.2    Hirota, Y.3
  • 111
    • 0034067992 scopus 로고    scopus 로고
    • Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta
    • Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. J Neurochem 2000;74(4):1587-1595.
    • (2000) J Neurochem , vol.74 , Issue.4 , pp. 1587-1595
    • Reynolds, C.H.1    Betts, J.C.2    Blackstock, W.P.3    Nebreda, A.R.4    Anderton, B.H.5
  • 112
    • 0033782845 scopus 로고    scopus 로고
    • Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease
    • Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 2000;59(10):880-888.
    • (2000) J Neuropathol Exp Neurol , vol.59 , Issue.10 , pp. 880-888
    • Zhu, X.1    Rottkamp, C.A.2    Boux, H.3    Takeda, A.4    Perry, G.5    Smith, M.A.6
  • 113
    • 12144278195 scopus 로고    scopus 로고
    • Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains
    • Luth HJ, Ogunlade V, Kuhla B, et al. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 2005;15(2):211-220.
    • (2005) Cereb Cortex , vol.15 , Issue.2 , pp. 211-220
    • Luth, H.J.1    Ogunlade, V.2    Kuhla, B.3
  • 114
    • 13244270042 scopus 로고    scopus 로고
    • Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment
    • Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment. J Neurochem 2005;92(2):255-263.
    • (2005) J Neurochem , vol.92 , Issue.2 , pp. 255-263
    • Ahmed, N.1    Ahmed, U.2    Thornalley, P.J.3    Hager, K.4    Fleischer, G.5    Munch, G.6
  • 115
    • 0037332634 scopus 로고    scopus 로고
    • Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia
    • Bar KJ, Franke S, Wenda B, et al. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia. Neurobiol Aging 2003;24(2):333-338.
    • (2003) Neurobiol Aging , vol.24 , Issue.2 , pp. 333-338
    • Bar, K.J.1    Franke, S.2    Wenda, B.3
  • 117
    • 84879640156 scopus 로고    scopus 로고
    • Glycation exacerbates the neuronal toxicity of beta-amyloid
    • Li XH, Du LL, Cheng XS, et al. Glycation exacerbates the neuronal toxicity of beta-amyloid. Cell Death Dis 2013;4:e673.
    • (2013) Cell Death Dis , vol.4 , pp. e673
    • Li, X.H.1    Du, L.L.2    Cheng, X.S.3
  • 118
    • 79551490365 scopus 로고    scopus 로고
    • Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures
    • Labuzek K, Liber S, Gabryel B, Okopien B. Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures. Pharmacol Rep 2010;62(5):827-848.
    • (2010) Pharmacol Rep , vol.62 , Issue.5 , pp. 827-848
    • Labuzek, K.1    Liber, S.2    Gabryel, B.3    Okopien, B.4
  • 119
    • 79551493930 scopus 로고    scopus 로고
    • Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
    • Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 2010;62(5):956-965.
    • (2010) Pharmacol Rep , vol.62 , Issue.5 , pp. 956-965
    • Labuzek, K.1    Suchy, D.2    Gabryel, B.3    Bielecka, A.4    Liber, S.5    Okopien, B.6
  • 120
    • 84862199583 scopus 로고    scopus 로고
    • Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
    • Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, Tsai HN. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 2012;18(6):753-758.
    • (2012) Parkinsonism Relat Disord , vol.18 , Issue.6 , pp. 753-758
    • Wahlqvist, M.L.1    Lee, M.S.2    Hsu, C.C.3    Chuang, S.Y.4    Lee, J.T.5    Tsai, H.N.6
  • 121
    • 79956277464 scopus 로고    scopus 로고
    • Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin
    • Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011;24(3):485-493.
    • (2011) J Alzheimers Dis , vol.24 , Issue.3 , pp. 485-493
    • Hsu, C.C.1    Wahlqvist, M.L.2    Lee, M.S.3    Tsai, H.N.4
  • 122
    • 78650746798 scopus 로고    scopus 로고
    • Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
    • Kickstein E, Krauss S, Thornhill P, et al. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A 2010;107(50):21830-21835.
    • (2010) Proc Natl Acad Sci U S A , vol.107 , Issue.50 , pp. 21830-21835
    • Kickstein, E.1    Krauss, S.2    Thornhill, P.3
  • 123
    • 79952439187 scopus 로고    scopus 로고
    • Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes
    • Gupta A, Bisht B, Dey CS. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology 2011;60(6):910-920.
    • (2011) Neuropharmacology , vol.60 , Issue.6 , pp. 910-920
    • Gupta, A.1    Bisht, B.2    Dey, C.S.3
  • 124
    • 84907032242 scopus 로고    scopus 로고
    • Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice
    • Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience 2014;277:747-754.
    • (2014) Neuroscience , vol.277 , pp. 747-754
    • Patil, S.P.1    Jain, P.D.2    Ghumatkar, P.J.3    Tambe, R.4    Sathaye, S.5
  • 125
    • 17944398255 scopus 로고    scopus 로고
    • Metformin inhibition of glycation processes
    • Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab 2003;29(4 Pt 2):6S95-103.
    • (2003) Diabetes Metab , vol.29 , Issue.4 , pp. 6S95-6103
    • Beisswenger, P.1    Ruggiero-Lopez, D.2
  • 126
    • 84869498086 scopus 로고    scopus 로고
    • Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression
    • Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. Hormone Metab Res 2012;44(12):891-895.
    • (2012) Hormone Metab Res , vol.44 , Issue.12 , pp. 891-895
    • Ishibashi, Y.1    Matsui, T.2    Takeuchi, M.3    Yamagishi, S.4
  • 127
    • 46749116766 scopus 로고    scopus 로고
    • Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells
    • Schurman L, McCarthy AD, Sedlinsky C, et al. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes 2008;116(6):333-340.
    • (2008) Exp Clin Endocrinol Diabetes , vol.116 , Issue.6 , pp. 333-340
    • Schurman, L.1    McCarthy, A.D.2    Sedlinsky, C.3
  • 128
    • 84873403513 scopus 로고    scopus 로고
    • An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes
    • Puddu A, Mach F, Nencioni A, Viviani GL, Montecucco F. An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. Mediators Inflamm 2013;2013:591056.
    • (2013) Mediators Inflamm , vol.2013 , pp. 591056
    • Puddu, A.1    Mach, F.2    Nencioni, A.3    Viviani, G.L.4    Montecucco, F.5
  • 129
    • 70349334516 scopus 로고    scopus 로고
    • Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
    • Kim S, Moon M, Park S. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease. J Endocrinol 2009;202(3):431-439.
    • (2009) J Endocrinol , vol.202 , Issue.3 , pp. 431-439
    • Kim, S.1    Moon, M.2    Park, S.3
  • 130
    • 59049087723 scopus 로고    scopus 로고
    • GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and parkinsonism
    • Li Y, Perry T, Kindy MS, et al. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and parkinsonism. Proc Natl Acad Sci U S A 2009;106(4):1285-1290.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.4 , pp. 1285-1290
    • Li, Y.1    Perry, T.2    Kindy, M.S.3
  • 131
    • 84878542289 scopus 로고    scopus 로고
    • Exenatide and the treatment of patients with Parkinson's disease
    • Aviles-Olmos I, Dickson J, Kefalopoulou Z, et al. Exenatide and the treatment of patients with Parkinson's disease. J Clin Invest 2013;123(6):2730-2736.
    • (2013) J Clin Invest , vol.123 , Issue.6 , pp. 2730-2736
    • Aviles-Olmos, I.1    Dickson, J.2    Kefalopoulou, Z.3
  • 132
    • 84904126994 scopus 로고    scopus 로고
    • Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease
    • Aviles-Olmos I, Dickson J, Kefalopoulou Z, et al. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease. J Parkinsons Dis 2014;4(3):337-344.
    • (2014) J Parkinsons Dis , vol.4 , Issue.3 , pp. 337-344
    • Aviles-Olmos, I.1    Dickson, J.2    Kefalopoulou, Z.3
  • 133
    • 79955749452 scopus 로고    scopus 로고
    • The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease
    • McClean PL, Parthsarathy V, Faivre E, Holscher C. The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 2011;31(17):6587-6594.
    • (2011) J Neurosci , vol.31 , Issue.17 , pp. 6587-6594
    • McClean, P.L.1    Parthsarathy, V.2    Faivre, E.3    Holscher, C.4
  • 134
    • 84929302567 scopus 로고    scopus 로고
    • Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes
    • Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. J Invest Med 2015;63(2):267-272.
    • (2015) J Invest Med , vol.63 , Issue.2 , pp. 267-272
    • Xu, W.1    Yang, Y.2    Yuan, G.3    Zhu, W.4    Ma, D.5    Hu, S.6
  • 135
    • 84942435321 scopus 로고    scopus 로고
    • Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
    • Solmaz V, Cinar BP, Yigitturk G, Cavusoglu T, Taskiran D, Erbas O. Exenatide reduces TNF-alpha expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats. Eur J Pharmacol 2015;765:482-487.
    • (2015) Eur J Pharmacol , vol.765 , pp. 482-487
    • Solmaz, V.1    Cinar, B.P.2    Yigitturk, G.3    Cavusoglu, T.4    Taskiran, D.5    Erbas, O.6
  • 136
    • 84895456459 scopus 로고    scopus 로고
    • Diabetes drugs and neurological disorders: new views and therapeutic possibilities
    • Patrone C, Eriksson O, Lindholm D. Diabetes drugs and neurological disorders: new views and therapeutic possibilities. Lancet Diabetes Endocrinol 2014;2(3):256-262.
    • (2014) Lancet Diabetes Endocrinol , vol.2 , Issue.3 , pp. 256-262
    • Patrone, C.1    Eriksson, O.2    Lindholm, D.3
  • 137
    • 77953880083 scopus 로고    scopus 로고
    • Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease
    • Holscher C. Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. Recent Pat CNS Drug Discov 2010;5(2):109-117.
    • (2010) Recent Pat CNS Drug Discov , vol.5 , Issue.2 , pp. 109-117
    • Holscher, C.1
  • 138
    • 0032857820 scopus 로고    scopus 로고
    • Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)
    • Freedman BI, Wuerth JP, Cartwright K, et al. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clinical Trials 1999;20(5):493-510.
    • (1999) Control Clinical Trials , vol.20 , Issue.5 , pp. 493-510
    • Freedman, B.I.1    Wuerth, J.P.2    Cartwright, K.3
  • 139
    • 84926681773 scopus 로고    scopus 로고
    • Recent development of plant products with anti-glycation activity: a review
    • Chinchansure AA, Korwar AM, Kulkarni MJ, Joshi SP. Recent development of plant products with anti-glycation activity: a review. RSC Advances 2015;5(39):31113-31138.
    • (2015) RSC Advances , vol.5 , Issue.39 , pp. 31113-31138
    • Chinchansure, A.A.1    Korwar, A.M.2    Kulkarni, M.J.3    Joshi, S.P.4
  • 140
    • 77950989148 scopus 로고    scopus 로고
    • The sour side of neurodegenerative disorders: the effects of protein glycation
    • Vicente Miranda H, Outeiro TF. The sour side of neurodegenerative disorders: the effects of protein glycation. J Pathol 2010;221(1):13-25.
    • (2010) J Pathol , vol.221 , Issue.1 , pp. 13-25
    • Vicente Miranda, H.1    Outeiro, T.F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.